4.6 Article

Modulation of α-synuclein aggregation by dopamine in the presence of MPTP and its metabolite

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Distinct Effects of Zn2+, Cu2+, Fe3+, and Al3+ on Amyloid-β Stability, Oligomerization, and Aggregation

Wei-Ting Chen et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

Amyloid formation and disaggregation of α-synuclein and its tandem repeat (α-TR)

Song Yi Bae et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2010)

Review Pharmacology & Pharmacy

The MPTP marmoset model of Parkinsonism: a multi-purpose non-human primate model for neurodegenerative diseases

Ingrid H. C. H. M. Philippens et al.

DRUG DISCOVERY TODAY (2010)

Article Chemistry, Multidisciplinary

In Vitro Formation of Amyloid from α-Synuclein Is Dominated by Reactions at Hydrophobic Interfaces

Jeremy Pronchik et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)

Article Biochemistry & Molecular Biology

Rasagiline protects against alpha-synuclein induced sensitivity to oxidative stress in dopaminergic cells

K. Y. Chau et al.

NEUROCHEMISTRY INTERNATIONAL (2010)

Article Biochemistry & Molecular Biology

Modulation of α-Synuclein Aggregation by Dopamine: A Review

Su Ling Leong et al.

NEUROCHEMICAL RESEARCH (2009)

Article Biochemistry & Molecular Biology

Amyloid toxicity is independent of polypeptide sequence, length and chirality

M. Teresa Pastor et al.

JOURNAL OF MOLECULAR BIOLOGY (2008)

Article Multidisciplinary Sciences

Mitochondrial complex I inhibition is not required for dopaminergic neuron death induced by rotenone, MPP+, or paraquat

Won-Seok Choi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Clinical Neurology

Mechanisms of neurodegeneration in idiopathic Parkinson's disease

Joerg B. Schulz

PARKINSONISM & RELATED DISORDERS (2007)

Article Biochemistry & Molecular Biology

Reversible inhibition of α-synuclein fibrillization by dopaminochrome-mediated conformational alterations

EH Norris et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2005)

Article Multidisciplinary Sciences

Parkinson-like syndrome induced by continuous MPTP infusion:: Convergent roles of the ubiquitin-proteasome system and α-synuclein

F Fornai et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

α-synuclein locus triplication causes Parkinson's disease

AB Singleton et al.

SCIENCE (2003)

Review Neurosciences

Parkinson's disease: Mechanisms and models

W Dauer et al.

NEURON (2003)

Article Multidisciplinary Sciences

Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP

W Dauer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)

Article Neurosciences

Environmental factors in Parkinson's disease

DA Di Monte et al.

NEUROTOXICOLOGY (2002)

Article Biochemistry & Molecular Biology

Evidence for a partially folded intermediate in α-synuclein fibril formation

VN Uversky et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)